Evolocumab
Amgen
['cardio']
overall results from #yellowiii trial: minimal fibrous cap thickness after 26 weeks maximum lcbi suggestive of overall plaque stabilization with this therapy!
#acc2023 #cardionerds 
Internal Medicine Resident at UPenn | Feinberg School of Medicine '16 | Views are my own